Michihiro Hosojima

Dr. Michihiro Hosojima

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2019 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
KTKoji Toba
Koji Toba
MHMichihiro Hosojima
Michihiro Hosojima
HKHideyuki Kabasawa
Hideyuki Kabasawa
SKShoji Kuwahara
Shoji Kuwahara
TMToshiko Murayama
Toshiko Murayama
ASAkihiko Saito
Akihiko Saito
Background: Dietary acid load has been suggested to mediate the progression of chronic kidney disease (CKD). However, it is unclear what kinds of foods are actually associated with dietary acid load in patients with CKD. The self-administered diet history questionnaire (DHQ), which semi-quantitatively assesses the dietary habits of Japanese individuals through 150 question items, can estimate average daily intake of various foods and nutrients during the previous month. Using the DHQ, we investigated the association of dietary acid load with CKD progression. We also analyzed the kinds of food that significantly affect dietary acid load. Methods: Subjects were 96 outpatients with CKD (average estimated glomerular filtration rate [eGFR], 53.0 ± 18.1 ml/min/1.73 m2) at Niigata University Hospital, who had completed the DHQ in 2011. We calculated net endogenous acid production (NEAP) from potassium and protein intake evaluated by the DHQ in order to assess dietary acid load. CKD progression was assessed by comparing eGFR between 2008 and 2014. Results: NEAP was not correlated with protein intake (r = 0.088, p = 0.398), but was negatively correlated with potassium intake (r = − 0.748, p < 0.001). Reduction in eGFR from 2008 to 2014 was estimated to be significantly greater in patients with higher NEAP (NEAP > 50.1 mEq/day, n = 45) than in those with lower NEAP (NEAP ≤50.1 mEq/day, n = 50) by 5.9 (95% confidence interval [95%CI], 0.1 to 11.6) ml/min/1.73 m2. According to multiple logistic regression analysis, higher NEAP was significantly associated with lower intake of fruits (odds ratio [OR], 6.454; 95%CI, 2.19 to 19.00), green and yellow vegetables (OR, 5.18; 95%CI, 1.83 to14.66), and other vegetables (OR, 3.87; 95%CI, 1.29 to 11.62). Conclusions: Elevated NEAP could be a risk factor for CKD progression. Low intake of fruits and vegetables would increase dietary acid load and might affect the progression of renal dysfunction in Japanese CKD patients.

1 January 2017 in Annals of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Open access
HSHiroki Sato
Hiroki Sato
MHMichihiro Hosojima
Michihiro Hosojima
TITomomi Ishikawa
Tomomi Ishikawa
KAKenji Aoki
Kenji Aoki
TOTakeshi Okamoto
Takeshi Okamoto
MTMasanori Tsuchida
Masanori Tsuchida
This purpose of this prospective study was to use a continuous glucose monitoring (CGM) system to evaluate the suitability of our institution's glucose management protocol after cardiovascular surgery and to clarify the impact of glycemic variability on postoperative complications. In all, 76 patients who underwent elective cardiovascular surgery and were monitored perioperatively using a CGM system were evaluated. Postoperative glucose management consisted of continuous intravenous insulin infusion (CIII) in the intensive care unit, and subcutaneous insulin injections (SQII) after oral food intake started. CIII and subcutaneous injections were initiated when blood glucose level exceeded 150 mg/dL. CGM data were used to analyze perioperative glycemic variability and association with postoperative complications. Target glucose levels (71-180 mg/dL) were achieved during 97.1 ± 5.5% and 86.4 ± 19.0% of the continuous insulin infusion and subcutaneous injection periods, respectively. Major postoperative complications were surgical site infections, found in 6.6% of total patients, and atrial fibrillation, found in 44% of patients with off-pump coronary artery bypass grafting. High glycemic variability during SQII was associated with increased risk for both complications. Data analysis revealed that our glucose management protocol during CIII was adequate. However, the management protocol during SQII required improvement.

2 December 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
YHYuki Higuchi
Yuki Higuchi
MHMichihiro Hosojima
Michihiro Hosojima
HKHideyuki Kabasawa
Hideyuki Kabasawa
SKShoji Kuwahara
Shoji Kuwahara
SGSawako Goto
Sawako Goto
ASAkihiko Saito
Akihiko Saito
Obesity and related disorders, which are increasing in adults worldwide, are closely linked to childhood diet and are associated with chronic inflammation. Rice endosperm protein (REP) intake during adulthood has been reported to improve lipid metabolism and suppress the progression of diabetic kidney disease in animal models. However, the effects of REP intake during childhood on adulthood health are unclear. Therefore, we used a mouse model to experimentally investigate the preconditioning effects of REP intake during childhood on the development of obesity and related disorders in adulthood. Male C57BL/6J mice were pair-fed a normal-fat diet containing casein or REP during the juvenile period and then a high-fat diet (HFD) containing casein or REP during adulthood. Mice fed REP during the juvenile period showed better body weight, blood pressure, serum lipid profiles, lipopolysaccharide (LPS)-binding protein levels, and glucose tolerance in adulthood than those fed casein during the juvenile period. HFD-induced renal tubulo-glomerular alterations and hepatic microvesicular steatosis were less evident in REP-fed mice than in casein-fed ones. REP intake during the juvenile period improved HFD-induced dysbiosis (i.e., Escherichia genus proliferation and reduced gut microbiota diversity), thereby suppressing endotoxin-related chronic inflammation. Indeed, REP-derived peptides showed antibacterial activity against Escherichia coli, a major producer of LPS. In conclusion, REP supplementation during the juvenile period may regulate the gut microbiota and thus suppress the development of obesity and related disorders in adulthood in mice.

21 May 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SGSawako Goto
Sawako Goto
ATAkihisa Tsutsumi
Akihisa Tsutsumi
YLYongchan Lee
Yongchan Lee
MHMichihiro Hosojima
Michihiro Hosojima
HKHideyuki Kabasawa
Hideyuki Kabasawa
ASAkihiko Saito
Akihiko Saito
Megalin (low-density lipoprotein receptor-related protein 2) is a giant glycoprotein of about 600 kDa, mediating the endocytosis of more than 60 ligands, including those of proteins, peptides, and drug compounds [S. Goto, M. Hosojima, H. Kabasawa, A. Saito,Int. J. Biochem. Cell Biol.157, 106393 (2023)]. It is expressed predominantly in renal proximal tubule epithelial cells, as well as in the brain, lungs, eyes, inner ear, thyroid gland, and placenta. Megalin is also known to mediate the endocytosis of toxic compounds, particularly those that cause renal and hearing disorders [Y. Horiet al.,J. Am. Soc. Nephrol.28, 1783–1791 (2017)]. Genetic megalin deficiency causes Donnai–Barrow syndrome/facio-oculo-acoustico-renal syndrome in humans. However, it is not known how megalin interacts with such a wide variety of ligands and plays pathological roles in various organs. In this study, we elucidated the dimeric architecture of megalin, purified from rat kidneys, using cryoelectron microscopy. The maps revealed the densities of endogenous ligands bound to various regions throughout the dimer, elucidating the multiligand receptor nature of megalin. We also determined the structure of megalin in complex with receptor-associated protein, a molecular chaperone for megalin. The results will facilitate further studies on the pathophysiology of megalin-dependent multiligand endocytic pathways in multiple organs and will also be useful for the development of megalin-targeted drugs for renal and hearing disorders, Alzheimer’s disease [B. V. Zlokovicet al.,Proc. Natl. Acad. Sci. U.S.A.93, 4229–4234 (1996)], and other illnesses.

30 May 2019 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
KKKeiko Kabasawa
Keiko Kabasawa
MHMichihiro Hosojima
Michihiro Hosojima
RTRibeka Takachi
Ribeka Takachi
KNKazutoshi Nakamura
Kazutoshi Nakamura
YIYumi Ito
Yumi Ito
NINarita Ichiei
Narita Ichiei
Acid-base imbalance might promote the progression of chronic kidney disease (CKD), but whether nutrient-derived dietary acid load increases the risk of albuminuria or even high normoalbuminuria is unclear. A Japanese cohort comprising 3250 men and 3434 women aged 40–97 years with urine albumin-to-creatinine ratio (ACR) < 33.9 mg/mmol or estimated glomerular filtration rate ≥ 15 ml/min/1.73 m2 were assessed. We performed a cross-sectional evaluation of the association between net endogenous acid production (NEAP), estimated as dietary protein to potassium content ratio, and the presence of high normoalbuminuria (ACR: 1.13–3.38 mg/mmol) or microalbuminuria. Median NEAP was 43.4 (interquartile range (IQR): 34.2–53.4) mEq/day in men and 35.0 (IQR: 27.7–43.6) mEq/day in women. Median ACR was 1.11 (IQR: 0.57–2.49) mg/mmol in men and 1.47 (IQR: 0.82–2.83) mg/mmol in women. In multivariate analysis, the adjusted odds ratio of the highest versus lowest NEAP quartile for microalbuminuria was 1.47 (95% confidence interval (CI): 1.08–1.99) in men and 1.54 (95% CI: 1.11–2.14) in women. For high normoalbuminuria or microalbuminuria, the adjusted odds ratio was 1.28 (95% CI: 1.02–1.59) in men and 1.39 (95% CI: 1.11–1.74) in women. From nutrient composition analysis, subjects with the highest potassium intake, but not protein intake, had lower adjusted odds ratios for the presence of microalbuminuria than those in the lowest quartile for potassium intake. Higher NEAP was associated with albuminuria and its association might negatively relate to potassium intake in an adult Japanese population.

9 May 2024 in The Journal of Pathology
Verified
Journal Article
Closed access
SGSawako Goto
Sawako Goto
MHMichihiro Hosojima
Michihiro Hosojima
HKHideyuki Kabasawa
Hideyuki Kabasawa
KAKaho Arai
Kaho Arai
KTKazuya Takemoto
Kazuya Takemoto
ASAkihiko Saito
Akihiko Saito